Delirium in Covid-19: Germany-wide Covid-19 Intensive Register
NCT ID: NCT04775017
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2398 participants
OBSERVATIONAL
2021-01-01
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
NCT05891873
Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital
NCT00604773
DELIRIUM SCREENING, INCIDENCE AND MANAGEMENT OBSERVATIONAL STUDY IN 2024 - THE CZECH REPUBLIC
NCT05841368
Retrospective Evaluation of Delirium Data From Previous Study Patients for Studies at the Clinic for Anesthesiology and Intensive Care Medicine CCM/CVK/CBF
NCT05913531
The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment
NCT01952899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age≥18 years
* Proven by positive PCR tests from nasal/ throat swabs as well as samples from the deep respiratory tract.
* Period 01.01.2020 to 21.02.2022
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Spies
Head of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Spies, MD, Prof.
Role: STUDY_DIRECTOR
Charité - Universitäsmedizin Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and Operative Intensive Care Medicine Campus Virchow-Klinikum
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-19-Delirium
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.